Pro Share Advisors LLC I Teos Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$16.57 - $35.1 $134,846 - $285,643	-8,138 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$31.92 - $47.45 $39,708 - $59,027	-1,244 Reduced 13.26%	8,138 $262,000
Q4 2021 Feb 08, 2022	SELL	$26.23 - $47.86 $19,095 - $34,842	-728 Reduced 7.2%	9,382 $437,000
Q3 2021 Nov 12, 2021	SELL	$23.91 - $29.58 $34,358 - $42,506	-1,437 Reduced 12.44%	10,110 $273,000
Q2 2021 Aug 13, 2021	BUY	$17.9 - $36.1 $25,489 - $51,406	1,424 Added 14.07%	11,547 $296,000
Q1 2021 May 14, 2021	BUY	$30.86 - $44.2 $69,033 - $98,875	2,237 Added 28.37%	10,123 $346,000
Q4 2020 Feb 09, 2021	BUY	$21.59 - $33.95 $170,258 - $267,729	7,886 New	7,886 $267,000

150

33.4M

454K

2.45M

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $245M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.